logowsbdaily | Tue, 25 Jan 2022 08:54:44 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

Cortexyme, Inc.
(CRTX)

Cortexyme, Inc.
269 East Grand Avenue
South San Francisco, CA 94080
United States
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease. Cortexyme, Inc. has a partnership with Parkinson Study Group. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Summary & Charts

Price$ 10.68+0.12 (+1.13%)
Day's Range$ 10.15 - 10.87 
Previous Close$ 10.56
Market Cap$ 319.09M USD
Short Interest %N/A
FloatN/A
OutstandingN/A
ExchangeNasdaqGS
IndustryBiotechnology
SectorHealthcare
Volume483.46K
Avg. Volume (20 day)1.04M
Rel. Volume (20 day)0.47
Rel. Volume (3 month)0.21
RatingBNeutral
DCFN/AStrong Buy
Debt/Equity11.13 %Neutral
ROE-57.73 %Sell
ROA-59.09 %Sell
P/E-3.65 %Strong Sell
P/B2.40 %Strong Buy
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Jan 14, 2022$ 10.18$ 10.87$ 10.15$ 10.68+0.12483,4590.470.21
Jan 13, 2022$ 11.12$ 11.25$ 10.48$ 10.56-0.48764,4230.720.34
Jan 12, 2022$ 11.71$ 11.77$ 11.00$ 11.04-0.59688,8440.610.31
Jan 11, 2022$ 11.40$ 12.04$ 11.37$ 11.63+0.05472,1170.410.21
Jan 10, 2022$ 11.72$ 11.94$ 11.35$ 11.58-0.47778,9730.660.36
Jan 07, 2022$ 11.89$ 12.36$ 11.70$ 12.05+0.11837,3130.710.39
Jan 06, 2022$ 12.14$ 12.54$ 11.54$ 11.94-0.21968,4990.820.46
Jan 05, 2022$ 12.77$ 13.27$ 11.82$ 12.15-0.85924,5950.760.451
Jan 04, 2022$ 13.18$ 13.40$ 12.64$ 13.00-0.39705,1510.580.351
Jan 03, 2022$ 12.62$ 13.70$ 12.37$ 13.39+0.771,012,1790.820.511
Dec 31, 2021$ 12.83$ 13.39$ 12.54$ 12.62-0.20730,7030.590.37
Dec 30, 2021$ 12.70$ 13.67$ 12.70$ 12.821,224,4270.950.611
Dec 29, 2021$ 12.11$ 12.95$ 12.00$ 12.82+0.61974,8480.710.48
Dec 28, 2021$ 12.44$ 13.20$ 12.15$ 12.21-0.301,004,6960.710.501
Dec 27, 2021$ 13.50$ 14.59$ 12.16$ 12.51-0.772,417,8451.681.18
Dec 23, 2021$ 12.68$ 13.62$ 12.63$ 13.28+0.44984,0040.730.48
Dec 22, 2021$ 12.80$ 12.94$ 12.13$ 12.84+0.031,240,4250.920.60
Dec 21, 2021$ 12.56$ 13.18$ 12.19$ 12.81+0.351,646,5531.230.80
Dec 20, 2021$ 11.93$ 12.78$ 11.51$ 12.46+0.29755,8160.570.36
Dec 17, 2021$ 11.83$ 12.55$ 11.37$ 12.17+0.352,094,5671.561.00

News

The latest news about Cortexyme, Inc. (CRTX).

The Motley Fool | 2022-01-12 10:00:00
A key clinical setback sent investors to the exits last year.
InvestorPlace | 2022-01-07 15:21:09
In a market made up of stocks, these three most-shorted stocks look poised to deliver a much happier 2022 to bullish investors. The post 3 Most-Shorted Stocks at 52-Week Lows to Buy appeared first on InvestorPlace.
InvestorPlace | 2021-12-17 13:50:21
Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we're diving into some top candidates! The post The 10 Most Shorted Stocks Right Now for Friday, Dec. 17 appeared first on InvestorPlace.
Seeking Alpha | 2021-12-15 15:46:12
CRTX reported partially promising results on October 26, 2021, which have been perceived as a complete failure by the market.
Benzinga | 2021-12-06 10:00:46
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile examples of short squeezes earlier this year.
Zacks Investment Research | 2021-12-01 10:44:19
Investors need to pay close attention to Cortexyme (CRTX) stock based on the movements in the options market lately.
Seeking Alpha | 2021-11-17 00:06:49
Cortexyme: A Challenging Path Forward

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2021-11-11BMO-0.73----------
2021-08-09BMO-0.7-0.745.71%------
2021-05-06BMO-0.72-0.788.33%------
2021-03-01BMO-0.73-0.695.48%------
2020-08-14BMO-0.62-0.603.23%------
2020-05-12BMO-0.44-0.6138.63%------
2020-03-16BMO-0.4-0.3512.5%------
2019-11-12BMO-0.37-0.37--------

Top Discussions

These are the top discussions over the last 24-hours that mention the CRTX stock ticker symbol.


Unusual Option Activity

Option contracts that are trading at a significantly higher volume relative to the contract's open interest. These might provide some insight into what "smart money" is doing with large volume orders.

TypeStrikeExp DateDTEBidAskLastVolumeOpen InterestVol/OIIV
CALL$ 2.5001/20/222$ 9.50$ 9.90$ 11.2020151.3323.97%
CALL$ 40.0004/13/2285$ 28.00$ 29.70$ 27.7040231.741.70%
CALL$ 80.0001/19/23366$ 0.55$ 1.70$ 1.1022141.571.38%
CALL$ 70.0001/19/23366$ 57.60$ 61.00$ 58.3355173.241.49%
Last Updated: Mon, 17 Jan 2022 22:49 EST

Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Tue, 14 Dec 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.